Innova Captab commences commercial production at Jammu facility

15 Jan 2025 Evaluate

Innova Captab has commenced commercial production at its state-of-the-art manufacturing facility in Kathua, Jammu. The facility comprises four dedicated manufacturing blocks including General, Cephalosporin, Penicillin and Penum with a capability to manufacture a diverse range of products in oral solid dosages, dry powder injectables, dry syrup, BFS, large volume parenterals and respiratory respule products.

With this expansion, the company, at a consolidated level, has total five manufacturing facilities with nine independent manufacturing blocks.

The facility has been established with a total capital outlay of more than Rs 450 crore and with the start of commercial production, the company is poised to benefit from the Central Government's 'New Central Sector Scheme’, for Capital Interest Subvention of 6% per annum and GST-linked incentive of 300% of investment made in plant and machinery in 10 years.

Innova Captab is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing.


Innova Captab Share Price

706.05 -2.80 (-0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×